Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP)Regulations, 2018 for quarter ended March 31, 2026
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company's Registrar and Transfer Agent, MUFG Intime India Private Limited, has issued a compliance certificate under SEBI regulations. This confirms that securities received for dematerialization during the quarter ending March 31, 2026 were properly verified, confirmed or rejected with depositories, and processed within prescribed timelines. The certificate also confirms that physical security certificates were mutilated and cancelled after due verification, and that depository details have been updated in the register of members. This is a routine regulatory filing required to be submitted quarterly to the stock exchange.
This filing is a standard compliance requirement with no direct impact on company financials or shareholder value. It simply confirms that share dematerialization processes were carried out correctly during the quarter.